In the Original Investigation titled “Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans”1 published on May 31, 2024, in JAMA Health Forum, there were errors in Table 1 and Table 3. In Table 1, there were some errors in the proportions by age. In Table 3, cells containing “1 [Reference]” have been corrected to “0 [Reference].” This article was corrected online.
Reference
- 1.Li Y, Heer AK, Sloane HS, et al. Budget impact analysis of circulating tumor DNA testing for colon cancer in commercial health and Medicare advantage plans. JAMA Health Forum. 2024;5(5):e241270. doi: 10.1001/jamahealthforum.2024.1270 [DOI] [PMC free article] [PubMed] [Google Scholar]
